Vitiligo: Causes, Symptoms, and How It’s Treated

Vitiligo is a chronic autoimmune skin condition where the body’s immune system mistakenly attacks the pigment-producing cells (melanocytes). This leads to the development of white or light-colored patches on the skin, which can vary in size and location.

Normally, melanocytes produce melanin, the pigment responsible for skin, hair, and eye color. In vitiligo, the destruction or dysfunction of these cells causes a loss of melanin, resulting in patches of depigmented (lighter) skin. These patches can appear anywhere, including the face, hands, feet, arms, scalp, and mucous membranes.

Types of Vitiligo

Vitiligo can be classified into several types based on the pattern and distribution of skin changes:

1. Segmental Vitiligo

Segmental Vitiligo usually begins at a young age and affects only one side or segment of the body. It spreads quickly at first but then stabilizes and does not usually progress further.  

2. Non-Segmental Vitiligo (Generalized Vitiligo)

Non-Segmental Vitiligo is the most common type, marked by symmetrical patches on both sides of the body. It can appear at any age and tends to progress gradually over time.  

3. Universal Vitiligo

Universal vitiligo is the most severe type of vitiligo. It is marked by the extensive loss of skin pigment that affects almost the entire body, including the face, trunk, and limbs.

4. Acrofacial Vitiligo

Acrofacial vitiligo is a form of vitiligo that causes white, depigmented patches primarily on the face, around the eyes, nose, and mouth, as well as on the hands and feet.

5. Mucosal Vitiligo

Mucosal vitiligo is a type of vitiligo that affects the mucous membranes, particularly in the mouth and genitals.

Causes of Vitiligo

Vitiligo arises due to multiple factors, often acting together, leading to the destruction of melanocytes (pigment-producing cells).

1. Autoimmune Factors

Vitiligo is primarily considered an autoimmune condition. The body’s immune system mistakenly attacks and destroys melanocytes, leading to depigmented skin patches. Certain immune-related abnormalities increase the risk of this process.

2. Genetic Predisposition

There is a hereditary component to vitiligo. Individuals with a family history of vitiligo or other autoimmune diseases have a higher likelihood of developing the condition. This raises the common question: Is vitiligo genetic or hereditary? Research shows that specific genes related to immune regulation and melanocyte function may contribute.

3. Environmental Triggers

External factors can trigger or worsen vitiligo in genetically susceptible individuals:

• Sunburn or skin trauma – damage to the skin may trigger local depigmentation.

• Stress – physical or emotional stress can influence immune activity.

• Chemical exposure – certain chemicals, like phenols in hair dyes or industrial chemicals, can damage melanocytes.

4. Associated Medical Conditions

Vitiligo is often linked with other autoimmune disorders, such as:

• Thyroid disease (e.g., Hashimoto’s thyroiditis, Graves’ disease)

• Type 1 diabetes

• Rheumatoid arthritis

• Pernicious anemia
  The presence of these conditions may increase susceptibility to developing vitiligo.

Symptoms of Vitiligo

1. Appearance of White Patches

The most noticeable symptom is the development of depigmented (white) patches on the skin. These patches may start small and gradually expand over time. They usually have well-defined edges.

2. Commonly Affected Areas

Vitiligo often affects areas with high sun exposure or friction, including:

• Hands and fingers

• Face, especially around the eyes and mouth

• Mouth and lips

• Genital areas

• Scalp (leading to white hair patches)

3. Changes in Hair Color

Hair in affected areas may also lose pigment, resulting in:

• Premature graying of scalp hair

• White or gray eyebrows, eyelashes, or beard hair

• Hair on depigmented patches turning completely white

4. Progression and Variability

• The condition progresses differently in each person. Some may develop only a few patches, while others experience widespread depigmentation.

• Patches may appear suddenly or gradually.

• The size, shape, and number of patches can change over time, sometimes stabilizing for years or spreading rapidly.

Diagnosis of Vitiligo

1. Medical History and Physical Examination

• A doctor will review the patient’s medical history, including family history of vitiligo or other autoimmune diseases.

• A physical exam helps identify the size, shape, and distribution of depigmented patches.

2. Wood’s Lamp Examination

• A Wood’s lamp (UV light) is often used to highlight depigmented areas.

• Under UV light, vitiligo patches glow bright white, making early or subtle patches easier to detect.

3. Blood Tests

• Blood tests may be done to check for associated autoimmune conditions, such as thyroid disease or diabetes.

• Tests may include thyroid function tests, blood sugar levels, and vitamin B12 levels.

{{vitiligo-cta-banner}}

Treatment Options for Vitiligo

Vitiligo is not harmful to your physical health, and treatment is generally cosmetic. Many people do not require treatment. However, if vitiligo is widespread or affects your emotional well-being, your healthcare provider can recommend options to either restore color (repigmentation) or even out skin tone by depigmentation.

Common Treatments for Vitiligo

1. Medications

While there is no medication that completely stops vitiligo, certain drugs can:

• Slow the progression of pigment loss

• Stimulate melanocytes to regrow

• Restore color to affected areas

Examples include:

• Corticosteroids – reduce inflammation and may help repigmentation

• Topical Janus kinase (JAK) inhibitors – such as ruxolitinib

• Calcineurin inhibitors – for sensitive areas like the face and neck

2. Light Therapy (Phototherapy)

Light therapy uses UV light or medical-grade lasers to stimulate melanocyte activity. Common approaches include:

• Narrowband UVB therapy – light is applied to affected skin for short sessions; multiple treatments may be needed to see results.

• PUVA therapy – combines oral psoralen with UVA light to treat larger areas, including the head, neck, trunk, and limbs.

3. Depigmentation Therapy

For people with extensive vitiligo, depigmentation therapy can remove remaining pigment to create a uniform skin tone.

• Uses monobenzone, applied to pigmented areas, turning them white to match vitiligo-affected skin.

4. Surgical Options

Surgery may be considered for stable vitiligo that does not respond to other treatments. Techniques include:

• Skin grafts – healthy skin is transplanted to depigmented areas. Risks: scarring, infection, or unsuccessful repigmentation.

Surgery is generally not recommended for:

• Rapidly spreading vitiligo

• People prone to keloid or raised scars

Furthermore, those interested in exploring potential new treatment options for vitiligo may consider participating in the Vitiligo Clinical Trial.

Conditions That Look Like Vitiligo

Some skin conditions may appear similar to vitiligo but have very different causes and treatments.

Hypopigmentation

In hypopigmentation vs vitiligo, Hypopigmentation is usually temporary or linked to an external factor, whereas vitiligo occurs due to autoimmune destruction of melanocytes.

Tinea Versicolor

The key difference in tinea versicolor vs vitiligo is that tinea versicolor results from an overgrowth of yeast on the skin and can be treated with antifungal medications, while vitiligo is an autoimmune condition.

Leukoderma

Leukoderma appears as white patches resulting from external damage, such as burns, trauma, or chemical exposure.

{{vitiligo-cta-banner}}

Conclusion:

In conclusion, vitiligo is a lifelong condition that affects both appearance and emotional well-being, but it is not physically harmful. With early diagnosis, treatment options, and proper support, people can manage symptoms effectively. Raising awareness, promoting acceptance, and encouraging research are essential steps toward improving the quality of life for individuals with vitiligo. In addition, you can explore new treatment possibilities for vitiligo and various other skin conditions through dermatology clinical research studies.